Founded in 1988 in Padua, Alifax operates in the laboratory diagnostics market, in particular in the hematology and microbiology fields. In only a few years, it established as a manufacturer of clinical diagnostic instruments for the analysis of ESR and rapid bacterial cultures, and begun a rapid spread in international markets. Currently, Alifax has branches in Russia, Spain, China, the United Arab Emirates, and Brazil; it also collaborates with relevant international commercial partners in over 90 other countries. Alifax has a strong orientation towards scientific research and technological innovation, supported by a well-funded investment program and, nowadays, it holds over 30 international patents. The company’s growing interest in innovation was consolidated in 2017 with the opening of a new department, Alifax Research & Development (R&D) Srl in Trieste in one of the national main science and technology parks (Area Science Park). Alifax R&D is a molecular biology laboratory fully equipped to undertake the research and development of cutting-edge diagnostic systems in the field of biomolecular medicine.